UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model

Gene therapy, 2015-05, Vol.22 (5), p.391-403

2015

Volltextzugriff (PDF)

Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice

Leukemia, 2017-10, Vol.31 (10), p.2114-2121

2017

Volltextzugriff (PDF)

Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells

Nature biotechnology, 1999-07, Vol.17 (7), p.670-675

1999

Volltextzugriff (PDF)

Deletion of Idiotype (Id)-Specific T Cells in Multiple Myeloma

Acta oncologica, 2000, Vol.39 (7), p.783-788

Bjarne Bogen, Karl Schenck, Ludvig A. Munthe, Zlatko Dembic

2000

Volltextzugriff (PDF)

POS0573 NEUTRALISING ANTIBODY RESPONSES TO BIVALENT SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.559-560

2024

Volltextzugriff (PDF)

POS0090 CELLULAR AND HUMORAL RESPONSES RESTORED BY UPDATED SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.314-315

2024

Volltextzugriff (PDF)

OP0085 LONGITUDINAL T CELL RESPONSES TO A SERIES OF FOUR SARS-COV-2 VACCINE DOSES OR COVID-19 IN PATIENTS ON TNF INHIBITORS

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.58-59

2023

Volltextzugriff (PDF)

OP0080 INCIDENCE AND CLINICAL OUTCOME OF COVID-19 RELATED TO POST-VACCINATION ANTIBODY LEVELS IN PATIENTS ON IMMUNOSUPPRESSIVE THERAPY: A PROSPECTIVE STUDY IN THE OMICRON ERA

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.55-56

2023

Volltextzugriff (PDF)

POS0537 SAFETY OF BIVALENT SARS-COV-2 VACCINES AS A SECOND BOOSTER DOSE IN ARTHRITIS PATIENTS ON IMMUNOSUPPRESSIVE THERAPIES

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.532-532

2023

Volltextzugriff (PDF)

OP0192 SEROLOGICAL RESPONSE AND SAFETY OF A THREE-DOSE SARS-CoV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.127-128

2022

Volltextzugriff (PDF)

OP0176 THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-CoV-2 VACCINES IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES USING IMMUNOSUPPRESSIVE THERAPY, COMPARED TO HEALTHY CONTROLS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.116-117

2022

Volltextzugriff (PDF)

Resting small B cells present endogenous immunoglobulin variable‐region determinants to idiotope‐specific CD4+ T cells in vivo

European journal of immunology, 1999-12, Vol.29 (12), p.4043-4052

1999

Volltextzugriff (PDF)

P1056 T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients with inflammatory bowel disease on TNF inhibitor treatment, a prospective cohort study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1901-i1902

2024

Volltextzugriff (PDF)

MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell Receptor ligation facilitates switch to IgG production

The Journal of immunology (1950), 2005-11, Vol.175 (9), p.6235-6235

2005

Volltextzugriff (PDF)

Preferential Positive Selection of T Lymphocytes which Express Two Different TCRα Chains, an Endogenous and a Transgenic

Scandinavian journal of immunology, 1995-12, Vol.42 (6), p.651-661

1995

Volltextzugriff (PDF)

Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells

Haematologica (Roma), 2016-02, Vol.101 (2), p.e59-e62

2016

Volltextzugriff (PDF)

P605 Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i537-i538

2022

Volltextzugriff (PDF)

B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives

Autoimmunity reviews, 2011-11, Vol.11 (1), p.28-34

2011

Volltextzugriff (PDF)

Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor

European journal of immunology, 1996-12, Vol.26 (12), p.2876-2884

1996

Volltextzugriff (PDF)

Systemic Autoimmune Disease Caused by Autoreactive B Cells That Receive Chronic Help from Ig V Region-Specific T Cells

The Journal of immunology (1950), 2005-08, Vol.175 (4), p.2391-2400

2005

Volltextzugriff (PDF)

Transient overexpression of CD4 enhances allelic exclusion of T-cell receptor (TCR) α chains and promotes positive selection of class II-restricted TCR-transgenic thymocytes

Molecular immunology, 1998, Vol.35 (1), p.23-38

1998

Volltextzugriff (PDF)

MHC-Restricted Ig V Region-Driven T-B Lymphocyte Collaboration: B Cell Receptor Ligation Facilitates Switch to IgG Production

The Journal of immunology (1950), 2004-06, Vol.172 (12), p.7476-7484

2004

Volltextzugriff (PDF)

Tracking Early Autoimmune Disease by Bioluminescent Imaging of NF-{kappa}B Activation Reveals Pathology in Multiple Organ Systems

The American journal of pathology, 2009-04, Vol.174 (4), p.1358-1367

2009

Volltextzugriff (PDF)

Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies

Blood, 2003-07, Vol.102 (2), p.605-612

2003

Volltextzugriff (PDF)

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models

Cancer Immunology, Immunotherapy, 2004-09, Vol.53 (9), p.759-769

2004

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(153)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model

Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice

Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells

Deletion of Idiotype (Id)-Specific T Cells in Multiple Myeloma

POS0573 NEUTRALISING ANTIBODY RESPONSES TO BIVALENT SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY

POS0090 CELLULAR AND HUMORAL RESPONSES RESTORED BY UPDATED SARS-CoV-2 VACCINES AND HYBRID IMMUNITY IN PATIENTS ON TNF INHIBITORS: A PROSPECTIVE COHORT STUDY

OP0085 LONGITUDINAL T CELL RESPONSES TO A SERIES OF FOUR SARS-COV-2 VACCINE DOSES OR COVID-19 IN PATIENTS ON TNF INHIBITORS

OP0080 INCIDENCE AND CLINICAL OUTCOME OF COVID-19 RELATED TO POST-VACCINATION ANTIBODY LEVELS IN PATIENTS ON IMMUNOSUPPRESSIVE THERAPY: A PROSPECTIVE STUDY IN THE OMICRON ERA

POS0537 SAFETY OF BIVALENT SARS-COV-2 VACCINES AS A SECOND BOOSTER DOSE IN ARTHRITIS PATIENTS ON IMMUNOSUPPRESSIVE THERAPIES

OP0192 SEROLOGICAL RESPONSE AND SAFETY OF A THREE-DOSE SARS-CoV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

OP0176 THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-CoV-2 VACCINES IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES USING IMMUNOSUPPRESSIVE THERAPY, COMPARED TO HEALTHY CONTROLS

Resting small B cells present endogenous immunoglobulin variable‐region determinants to idiotope‐specific CD4+ T cells in vivo

P1056 T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients with inflammatory bowel disease on TNF inhibitor treatment, a prospective cohort study

MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell Receptor ligation facilitates switch to IgG production

Preferential Positive Selection of T Lymphocytes which Express Two Different TCRα Chains, an Endogenous and a Transgenic

Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells

P605 Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study

B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives

Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor

Systemic Autoimmune Disease Caused by Autoreactive B Cells That Receive Chronic Help from Ig V Region-Specific T Cells

Transient overexpression of CD4 enhances allelic exclusion of T-cell receptor (TCR) α chains and promotes positive selection of class II-restricted TCR-transgenic thymocytes

MHC-Restricted Ig V Region-Driven T-B Lymphocyte Collaboration: B Cell Receptor Ligation Facilitates Switch to IgG Production

Tracking Early Autoimmune Disease by Bioluminescent Imaging of NF-{kappa}B Activation Reveals Pathology in Multiple Organ Systems

Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models

Suchergebnisse filtern